Korea Kolmar to develop topical agent for treatment of osteoporosis

Korea Kolmar is aiming to develop a new topical drug containing calcitonin and bisphosphonates to treat osteoporosis by spending 3.5 billion won for the next three years, under the joint collaboration with the Korea Research Institute of Chemical Technology and Sookmyung Women’s University’s pharmacy college.

The company says Korea Kolmar will conduct this year’s state-funded R& D project se...